Differential expression and functional analysis of the tristetraprolin family during early differentiation of 3T3-L1 preadipocytes

International Journal of Biological Sciences

Volumn 8, Issue 5, 2012, Pages 761-777

  Lin, Nien Yi ^a   Lin, Tzi Yang ^b   Yang, Wen Hsuan ^b   Wang, Shun Chang ^a   Wang, Kuan Ting ^b   Su, Yu Lun ^b   Jiang, Yu Wun ^b   Chang, Geen Dong ^b   Chang, Ching Jin ^a,b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

3T3 L1; AU rich element; MKP 1; Tristetraprolin; ZFP36L1; ZFP36L2

Indexed keywords

DUSP1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NUCLEAR PROTEIN; PROTEIN 14 3 3; RNA BINDING PROTEIN; TRISTETRAPROLIN; ZFP36 PROTEIN, MOUSE; ZFP36L1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN 3T3; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

14-3-3 PROTEINS; 3T3-L1 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; DUAL SPECIFICITY PHOSPHATASE 1; HUMANS; IMMUNOBLOTTING; MICE; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TRISTETRAPROLIN;

EID: 84863769150     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4036     Document Type: Article

References (61)

1. Blackshear PJ. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans. 2002; 30(Pt 6):945-52.
2. Baou M, Jewell A, Murphy JJ. TIS11 family proteins and their roles in posttranscriptional gene regulation. J Biomed Biotechnol. 2009; 2009:634520.
3. Blackshear PJ, Phillips RS, Ghosh S, et al. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod. 2005; 73(2):297-307.
4. Lykke-Andersen J, Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 2005; 19(3):351-61.
5. Blackshear PJ, Lai WS, Kennington EA, et al. Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J Biol Chem. 2003; 278(22):19947-55.
6. Brewer BY, Malicka J, Blackshear PJ, et al. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite na-ture of Au-rich MRNA-destabilizing motifs. J Biol Chem. 2004; 279(27):27870-7.
7. Lai WS, Kennington EA, Blackshear PJ. Tristetraprolin and its fam-ily members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol. 2003; 23(11):3798-812.
8. Lai WS, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J Biol Chem. 2001; 276(25):23144-54.
9. Benjamin D, Schmidlin M, Min L, et al. BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol Cell Biol. 2006; 26(24):9497-507.
10. Cao H, Deterding LJ, Venable JD, et al. Identification of the an-ti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis. Bio-chem J. 2006; 394:285-97.
11. Brook M, Tchen CR, Santalucia T, et al. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular sig-nal-regulated kinase pathways. Mol Cell Biol. 2006; 26(6):2408-18.
12. Hitti E, Iakovleva T, Brook M, et al. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol. 2006; 26(6):2399-407.
13. Maitra S, Chou CF, Luber CA, et al. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA. 2008; 14(5):950-9.
14. Chrestensen CA, Schroeder MJ, Shabanowitz J, et al. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem. 2004; 279(11):10176-84.
15. Johnson BA, Stehn JR, Yaffe MB, et al. Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and-independent mech-anisms. J Biol Chem. 2002; 277(20):18029-36.
16. Stoecklin G, Stubbs T, Kedersha N, et al. MK2-induced tristetrap-rolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 2004; 23(6):1313-24.
17. Marchese FP, Aubareda A, Tudor C, et al. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 dead-enylase recruitment. J Biol Chem. 2010; 285(36):27590-600.
18. Clement SL, Scheckel C, Stoecklin G, et al. Phosphorylation of Tristetraprolin by MK2 Impairs AU-Rich Element mRNA Decay by Preventing Deadenylase Recruitment. Mol Cell Biol. 2011; 31(2):256-66.
19. Sandler H, Kreth J, Timmers HT, et al. Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res. 2011; 39(10):4373-86.
20. Schmidlin M, Lu M, Leuenberger SA, et al. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J. 2004; 23(24):4760-9.
21. Carrick DM, Lai WS, Blackshear PJ. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res Ther. 2004; 6(6):248-64.
22. Taylor GA, Carballo E, Lee DM, et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity re-sulting from tristetraprolin (TTP) deficiency. Immunity. 1996; 4(5):445-54.
23. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macro-phage tumor necrosis factor-alpha production by tristetraprolin. Science. 1998; 281(5379):1001-5.
24. Stumpo DJ, Byrd NA, Phillips RS, et al. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol. 2004; 24(14):6445-55.
25. Ramos SB, Stumpo DJ, Kennington EA, et al. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development. Development. 2004; 131(19):4883-93.
26. Stumpo DJ, Broxmeyer HE, Ward T, et al. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding pro-tein, results in defective hematopoiesis. Blood. 2009; 114(12):2401-10.
27. Hodson DJ, Janas ML, Galloway A, et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol. 2010; 11(8):717-24.
28. Brooks SA, Connolly JE, Rigby WF. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extra-cellular signal-regulated kinase-specific, AU-rich ele-ment-dependent, autoregulatory pathway. J Immunol. 2004; 172(12):7263-71.
29. Lin NY, Lin CT, Chang CJ. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem Biophys Res Commun. 2008; 365(1):69-74.
30. Lin NY, Lin CT, Chen YL, et al. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes. FEBS J. 2007; 274(3):867-78.
31. Kuwano Y, Kim HH, Abdelmohsen K, et al. MKP-1 mRNA stabili-zation and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol. 2008; 28(14):4562-75.
32. Emmons J, Townley-Tilson WH, Deleault KM, et al. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA. 2008; 14(5):888-902.
33. Horner TJ, Lai WS, Stumpo DJ, et al. Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin. Mol Cell Biol. 2009; 29(8):1999-2010.
34. Lai WS, Parker JS, Grissom SF, et al. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol. 2006; 26(24):9196-208.
35. Cao H, Urban JF, Jr., Anderson RA. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes. Obesity (Silver Spring). 2008; 16(6):1208-18.
36. Hacker C, Valchanova R, Adams S, et al. ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production. Growth Factors. 2010; 28(3):178-90.
37. Carrick DM, Blackshear PJ. Comparative expression of tristetrap-rolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch Biochem Biophys. 2007; 462(2):278-85.
38. Liang J, Song W, Tromp G, et al. Genome-wide survey and expres-sion profiling of CCCH-zinc finger family reveals a functional module in macrophage activation. PLoS One. 2008; 3(8):e2880.
39. Sun L, Stoecklin G, Van Way S, et al. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by pro-tein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem. 2007; 282(6):3766-77.
40. Kedar VP, Darby MK, Williams JG, et al. Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85. PLoS One. 2010; 5(3):e9588.
41. Twizere JC, Kruys V, Lefebvre L, et al. Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst. 2003; 95(24):1846-59.
42. Tang QQ and Lane MD. Adipogenesis: From stem cell to adipocyte. Annu. Rev. Bioch. 2012; 81:21.1-21.22.
43. Bost F, Aouadi M, Caron L, et al. The role of MAPKs in adipocyte differentiation and obesity. Biochimie. 2005; 87(1):51-6.
44. Keyse SM. Protein phosphatases and the regulation of mito-gen-activated protein kinase signalling. Curr Opin Cell Biol. 2000; 12(2):186-92.
45. Pouyssegur J, Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem. 2003; 270(16):3291-9.
46. Tamura S, Hanada M, Ohnishi M, et al. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur J Biochem. 2002; 269(4):1060-6.
47. Keyse SM, Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992; 359(6396):644-7.
48. Liu Y, Gorospe M, Yang C, et al. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. Inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J Biol Chem. 1995; 270(15):8377-80.
49. Brondello JM, Brunet A, Pouyssegur J, et al. The dual specificity mitogen-activated protein kinase phosphatase-1 and-2 are induced by the p42/p44MAPK cascade. J Biol Chem. 1997; 272(2):1368-76.
50. Xu Q, Fawcett TW, Gorospe M, et al. Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension. Hyper-tension. 1997; 30:106-11.
51. Kassel O, Sancono A, Kratzschmar J, et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001; 20(24):7108-16.
52. Ito A, Suganami T, Miyamoto Y, et al. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. J Biol Chem. 2007; 282(35):25445-52.
53. Sale EM, Atkinson PG, Sale GJ. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthe-sis. EMBO J. 1995; 14(4):674-84.
54. Benito M, Porras A, Nebreda AR, et al. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science. 1991; 253(5019):565-8.
55. Porras A, Nebreda AR, Benito M, et al. Activation of Ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phos-phorylation. J Biol Chem. 1992; 267(29):21124-31.
56. Li J, Gorospe M, Hutter D, et al. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphoryla-tion-acetylation. Mol Cell Biol. 2001; 21(23):8213-24.
57. Lasa M, Abraham SM, Boucheron C, et al. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol. 2002; 22(22):7802-11.
58. Busse M, Schwarzburger M, et al. Strong induction of the Tis11B gene in myogenic differentiation. Eur J Cell Biol. 2008; 87(1):31-8.
59. Wegmuller D, Raineri I, Gross B, et al. A cassette system to study embryonic stem cell differentiation by inducible RNA interference. Stem Cells. 2007; 25(5):1178-85.
60. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem. 1995; 64:345-73.
61. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006; 4(4):263-73.